Tecentriq

408,260

Product Type Product Size
Injection 1’S
Product Company
Roche Pharma

Atezolizumab 1200mg/20ml

Category:

Description


Atezolizumab, sold under the brand name Tecentriq, is a monoclonal antibody medication used to treat urothelial carcinoma, non-small cell lung cancer, triple-negative breast cancer, small cell lung cancer, hepatocellular carcinoma, and alveolar soft part sarcoma.

Reviews

There are no reviews yet.

Be the first to review “Tecentriq”

Your email address will not be published. Required fields are marked *

Quick Comparison

SettingsTecentriq removeDarbazine removeTrastuget removeLetrasan removeSedol removeAvastin 400mg/16ml remove
NameTecentriq removeDarbazine removeTrastuget removeLetrasan removeSedol removeAvastin 400mg/16ml remove
Image
SKU
Rating
Price408,260782101,6047,609550137,400
Stock
Availability
Add to cart

Description
Product Type Product Size
Injection 1'S
Product Company
Roche Pharma
Atezolizumab 1200mg/20ml
Product Type Product Size
injection 1'S
Product Company
Pharmedic
Dacarbazine 200mg
Product Type Product Size
Injection 1'S
Product Company
Getz Pharma
Trastuzumab 440mg/10ml
Product Type Product Size
Tablet 30'S
Product Company
Manufacture Deva Holding / Marketed by Searle
Letrozole 2.5mg
Product Type Product Size
Injection 1'S
Product Company
Helix pharma
100mg/5ml
Product Type Product Size
Injection 1'S
Product Company
Roche Pharma
Bevacizumab 400mg/16ml
Content" Atezolizumab, sold under the brand name Tecentriq, is a monoclonal antibody medication used to treat urothelial carcinoma, non-small cell lung cancer, triple-negative breast cancer, small cell lung cancer, hepatocellular carcinoma, and alveolar soft part sarcoma.Dacarbazine, also known as imidazole carboxamide, is a chemotherapy medication used in the treatment of melanoma and Hodgkin's lymphoma. For Hodgkin's it is often used together with vinblastine, bleomycin, and doxorubicin.Trastuzumab is a monoclonal anti-human epidermal growth factor receptor 2 protein antibody used to treat HER2-positive breast, gastroesophageal, and gastric cancers.Letrozole is a non-steroidal type II aromatase inhibitor. It blocks the active site, and therefore the electron transfer chain of CYP19A1. This competitive inhibition prevents the conversion of androgens to estrogen. This action leads to a reduction in uterine weight and elevated leuteinizing hormon.Etoposide is a podophyllotoxin derivative used to treat testicular and small cell lung tumors. " Bevacizumab is a type of targeted cancer drug treatment. It is also known as Avastin. It is a treatment for a number of different cancer types.
WeightN/AN/AN/AN/AN/AN/A
DimensionsN/AN/AN/AN/AN/AN/A
Additional information